Signaling Pathways - Glutamate (Metabotropic) Group I Receptors - CRTH2 - PAR receptor - Insulin and Insulin-like Receptors
清除全部
-
B5705 Q94 hydrochlorideTarget: PAR receptorSummary: PAR1负变构调节剂 -
B5532 NPS 2390Target: Glutamate (Metabotropic) Group I ReceptorsSummary: I型mGlu拮抗剂 -
B6569 CHPGTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: mGlu5代谢型谷氨酸受体激动剂 -
B1534 AZD1981Target: CRTH2Summary: CRTh2拮抗剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3633 MPEP HydrochlorideTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: MGlu5受体拮抗剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂